Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development
April 29, 2024 | Insights, US, healthcare, market research
Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and client management. Throughout her career, Kathy has worked extensively at guiding her clients to identify the optimal research approach to address the business issue at hand. In Kathy’s most recent position as Senior Vice President, Business Development at ThinkGen, she was responsible for implementing the business development and marketing strategy and overseeing all client outreach.
In 2023, Kathy was honored with the Healthcare Businesswomen’s Association (HBA) Luminary Award which recognizes professionals who have made a significant impact on the healthcare industry and have a proven track record of helping advance careers of other women. Kathy also volunteered as a HBA mentor as part of the HBA Mentoring Program.
In this pivotal role at Research Partnership, Kathy will be working with our Commercial Team to identify new business opportunities, nurture existing partnerships and enhance our US based presence in the market.
US President, Sue Wild commented “I am delighted to welcome Kathy to the team, she has extensive experience and will be instrumental in nurturing our client relationships in the US market. I look forward to collaborating with Kathy to strengthen our offerings in delivering the best possible insights for our valued clients”.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Infographic: Are data blind spots putting your launch at risk?
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…
Key takeaways from ASCO® 2026
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…
Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the…
Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact
Discover how AI, analytics and real-world data are reshaping Medical Affairs.
How did multifaceted support from across Inizio help a biotech firm prepare for launch?
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.
Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency
Explore Inizio Medical’s key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.